Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy | Zendy

Hisatomi Arima | Zendy; Christophe Tzourio | Zendy; Craig S. Anderson | Zendy; Mark Woodward | Zendy; M G Bousser | Zendy; Stephen MacMahon | Zendy; Bruce Neal | Zendy; John Chalmers | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy

Author(s) -

Hisatomi Arima,

Christophe Tzourio,

Craig S. Anderson,

Mark Woodward,

M G Bousser,

Stephen MacMahon,

Bruce Neal,

John Chalmers

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.109.563932

Subject(s) - medicine , cerebral amyloid angiopathy , intracerebral hemorrhage , indapamide , contraindication , perindopril , blood pressure , placebo , stroke (engine) , randomized controlled trial , cardiology , disease , dementia , subarachnoid hemorrhage , pathology , mechanical engineering , alternative medicine , engineering

Patients with cerebral amyloid angiopathy (CAA) are at high risk for intracerebral hemorrhage (ICH), but no effective prevention strategies have been established. The objective is to determine whether lowering of blood pressure (BP) provides protection for this high-risk patient group.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research